Delivery Order SPE2DB22D9304-SPE2DB25FSTA6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,136.66 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml autoinjector on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, was issued without set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL. The award...
- The Defense Logistics Agency awarded a delivery order valued at $8,561.10 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/mL auto-injectors, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was issued on July 21, 2025, without a set-aside designation. The delivery location is Park Ridge, Illinois, where DMS Pharmaceutical Group Inc. maintains its operations as a woman-owned small business pharmaceutical wholesaler. The award represents...
- The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc. for Xolair 300 mg/2 mL auto-injector syringes on August 19, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a specific pharmaceutical product requirement to be delivered to Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $10,273.38 by the Defense Logistics Agency on August 15, 2025, for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, carries no set-aside designation. The award represents a discrete fulfillment order issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $27,395.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL auto-injector medications. This firm fixed-price delivery order was issued on August 19, 2025, with an ultimate completion date of September 10, 2025, and does not utilize a set-aside designation. The award represents a specific fulfillment under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,712.23 to DMS Pharmaceutical Group Inc. for the supply of Xolair 300 mg/2 ml auto-injector units. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge. The award was issued on August 25, 2025, with an ultimate completion date of September 16, 2025, and was not designated under any federal...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on August 21, 2025, for the supply of Xolair 300 mg/2 mL auto-injector units valued at $13,697.84. This firm fixed-price delivery order, with an ultimate completion date of September 12, 2025, represents a specific pharmaceutical product pull under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The contract contains no set-aside designation and will be performed in Park Ridge,...
- The Defense Logistics Agency awarded a $12,841.65 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 24, 2025, for the supply of Xolair 150 mg/mL auto-injector medication. The contract, which must be completed by August 14, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL 60068. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of September 9, 2025, represents a specific product fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector vials. The delivery order, valued at $6,848.92 with a firm fixed price arrangement, is scheduled for completion by September 9, 2025, and was issued on August 18, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in...
- SPE2DB22D9304Indefinite Delivery Contract
- SPE2DB22D9304-SPE2DB25FSTA6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,136.69 to DMS Pharmaceutical Group Inc. on August 25, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a continuation of the agency's pharmaceutical supply chain operations. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation, leveraging its competitive positioning in federal procurement markets. This award is issued under DMS Pharmaceutical Group's significant single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The larger vehicle enables the agency to issue firm fixed-price delivery orders for pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of contract awards covering an extensive range of prescription medications, biologics, auto-injectors, and specialized pharmaceutical products to military and federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 8/25/25 |